EUVIMEDAvasta EUVIMED
CrossrefInfokaart

Comparison of autologous venous grafts and three types of extracellular matrix grafts in Peyronie’s disease surgery

TÜRKER SOYDAŞ, SELMAN ÜNAL, HALİL UZUNDAL, MERVE KAŞIKCI, MUSAB ALİ KUTLUHAN, EMRAH OKULU, ÖNDER KAYIGİL

Turkish Journal of Medical Sciences · 2024-10-18 · 54 (5) · 893-899

DOI: 10.55730/1300-0144.5865 ↗
AbstraktBibliograafilised andmed

Abstrakt

Background/aimPeyronie's Disease (PD) is known as a wound-healing disorder, for which surgery remains the gold standard treatment, but studies comparing graft materials are few in the literature. The aim of this study is to evaluate the mid- and long-term results of patients who had Peyronie's surgery with grafting procedures performed by a single experienced surgeon, according to the graft materials.Materials and methodsPatients who underwent corporoplasty between 2014 and 2020 with grafting procedures by a single experienced surgeon were retrospectively reviewed. 115 patients were divided into 4 groups according to the graft material used: autologous saphenous venous graft, Group 1 (n=36); porcine pericardial extracellular matrix graft (EMG; XenoGuard, (MBP – MEDICAL BIOMATERIAL PRODUCTS GmbH, Neustadt-Glewe, Germany), Group 2 (n=40); porcine intestinal submucosal EMG (BioDesign, COOK MEDICAL, Bloomington, IN, USA), Group 3 (n=36); bovine pericardial EMG (Tutopatch, Tutogen Medical, Inc., Alachua, FL, USA), Group 4 (n=43).ResultsThe mean operation time for Group 1 was longer than the other groups (p

Teadmised, mis sobivad teie tööga.

Tasuta alustamisest ja isiklikust kirjanduse otsingust kuni täieliku Research Suite’ini.

Vaata pakette →

Kas kõik kirjastajate täistekstid on kaasatud?

Ei. Bibliograafilised kirjed, kokkuvõtted ja täistekstid on erinevad sisud. See, kas täistekst on saadaval, sõltub allikast, Open Accessist ja teie olemasolevatest litsentsidest. EUVIMED-i pakett ei asenda täiendavaid kirjastajaõigusi.

Vaata pakette →